MiR-509-3p promotes gastric cancer development by activating FOXM1-mediated p38/MK2 pathway. Biomol Biomed [Internet]. 2024 Dec. 11 [cited 2025 Jan. 21];25(1):177–188. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/11104